Professor
Department of Medicine, Division of Medical Oncology
Clinical Director, Genitourinary Cancers Program
University of Washington
Professor, Clinical Research Division
Fred Hutchinson Cancer Center
Seattle, WA
Dr. Petros Grivas is a board-certified medical oncologist with expertise and experience in treating genitourinary (GU) cancers. He is a Professor and the Clinical Director of the Genitourinary Cancers Program at the University of Washington and Fred Hutchinson Cancer Center. Dr. Grivas completed his training at the University of Patras Medical School and earned his M.D. degree in 2005; he then pursued Ph.D. in Medical Oncology under the mentorship of academic faculty and defended his thesis successfully in late 2008. He completed his Residency in Internal Medicine at Hahnemann University Hospital/Drexel University College of Medicine (Philadelphia, USA) in 2010. He then completed his Fellowship in Hematology/Oncology at University of Michigan (Ann Arbor, USA) in 2013. He stayed there as Clinical Lecturer for another year before he was recruited as Assistant Professor at the Cleveland Clinic (Cleveland, USA), where he was leading the bladder/urothelial cancer program, pursuing clinical and translational research, teaching and mentoring trainees, and seeing patients with GU cancers.
He has had a main role in large clinical trials that led to the FDA approval of new drugs for bladder/urothelial cancer (e.g. avelumab switch maintenance based on Javelin Bladder100, sacituzumab govitecan based on TROPHY-U-01), and is considered a key opinion, thought leader and international expert, giving lectures in several countries, educating oncologists and other healthcare providers, mentoring trainees, leading large innovative clinical trials and retrospective studies, reviewing grants and manuscripts, and publishing novel, important research. He is dedicated to efficient, personalized and outstanding patient care and believes in optimal patient-physician relationship as well as community outreach. He has leadership roles in various committees and supports equity, diversity, and inclusion.
